trending Market Intelligence /marketintelligence/en/news-insights/trending/rmuyyq3hxcfvgxf2cchdsw2 content esgSubNav
In This List

Processa Pharmaceuticals appoints CFO

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Processa Pharmaceuticals appoints CFO

Processa Pharmaceuticals Inc. appointed James Stanker as its CFO.

The Hanover, Md.-based company said Stanker brings more than 25 years of financial and executive leadership experience to Processa in the areas of accounting principles and audit standards, regulatory reporting and fiscal management and strategy.

Processa Pharmaceuticals is developing a medicine for a skin condition known as necrobiosis lipoidica.